MiMedx Group, Inc.
MDXG
$6.96
-$0.21-2.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 88.21M | 92.91M | 84.06M | 87.21M | 84.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 88.21M | 92.91M | 84.06M | 87.21M | 84.71M |
| Cost of Revenue | 16.56M | 16.91M | 15.32M | 14.86M | 12.99M |
| Gross Profit | 71.65M | 76.00M | 68.74M | 72.35M | 71.72M |
| SG&A Expenses | 59.97M | 61.09M | 54.17M | 45.70M | 55.44M |
| Depreciation & Amortization | 99.00K | 193.00K | 192.00K | 190.00K | 189.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 79.95M | 81.76M | 72.60M | 63.76M | 71.46M |
| Operating Income | 8.25M | 11.15M | 11.46M | 23.45M | 13.25M |
| Income Before Tax | 8.61M | 11.25M | 11.42M | 23.22M | 11.41M |
| Income Tax Expenses | 1.59M | 3.81M | 3.54M | 5.60M | 2.35M |
| Earnings from Continuing Operations | 7.02M | 7.44M | 7.88M | 17.62M | 9.06M |
| Earnings from Discontinued Operations | -- | 0.00 | 217.00K | 4.00K | 200.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.02M | 7.44M | 8.10M | 17.63M | 9.26M |
| EBIT | 8.25M | 11.15M | 11.46M | 23.45M | 13.25M |
| EBITDA | 11.48M | 14.14M | 12.62M | 24.58M | 14.02M |
| EPS Basic | 0.05 | 0.05 | 0.06 | 0.12 | 0.06 |
| Normalized Basic EPS | 0.04 | 0.05 | 0.05 | 0.10 | 0.05 |
| EPS Diluted | 0.05 | 0.05 | 0.05 | 0.12 | 0.06 |
| Normalized Diluted EPS | 0.04 | 0.05 | 0.05 | 0.10 | 0.05 |
| Average Basic Shares Outstanding | 147.27M | 147.01M | 146.96M | 147.33M | 146.40M |
| Average Diluted Shares Outstanding | 149.68M | 149.24M | 148.37M | 148.90M | 150.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 2.42% | -- | -- | -- | -- |